Guardant Health Inc at Cowen HealthCare Conference Transcript
All right. Good morning. It's our pleasure to welcome Helmy Eltoukhy, and Derek Bertocci from -- Derek Bertocci, excuse me, from Guardant Health. Guardant Health is a molecular diagnostic company that provides comprehensive genomic profiling and other services to clinical and biopharmaceutical customers. We believe Guardant's liquid biopsy panels are well positioned to outpace tissue-based competitors due to the advantages of blood-based profiling and Guardant's strong supporting data and commercial prowess. Over the next 25 to 30 minutes, we're going to talk about the 2020 outlook, progress with reimbursement and regulation, an update on G360 commercial efforts and on this growing traction amongst biopharmaceutical partners. If we have time, we hope to close with a discussion of pipeline developments and associated timelines for LUNAR.
Questions & Answers
So thanks,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |